Company intelligence / Profile preview

Siyan Clinical Corporation

Santa Rosa, California, United States

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Siyan Clinical provides commercial outpatient psychiatric care, including advanced treatments such as TMS and SPRAVATO for treatment-resistant depression. No drug development or clinical trial pipeline; focus on patient care delivery.

Therapeutic areas: Psychiatry
Modalities: Device (Transcranial Magnetic Stimulation)Small molecule (esketamine via SPRAVATO)Non-pharmacological therapy (Intensive Outpatient Program)
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

esketamine

Commercial

Indications: Major Depressive Disorder, Treatment-resistant Depression

Partnerships

None found; operates independently as a regional practice.

Beyond the preview

Go deeper on Siyan Clinical Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siyan Clinical Corporation.

Explore the full profile